WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007085019) METHODS OF TREATING OR PREVENTING SINUSITIS WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/085019    International Application No.:    PCT/US2007/060856
Publication Date: 26.07.2007 International Filing Date: 22.01.2007
IPC:
A61K 33/40 (2006.01), A61P 29/00 (2006.01)
Applicants: OCULUS INNOVATIVE SCIENCES, INC. [US/US]; 1129 North McDowell Boulevard, Petaluma, California 94954 (US) (For All Designated States Except US).
ALIMI, Hojabr [US/US]; (US) (For US Only).
GUTIÉRREZ, Andrés [MX/US]; (US) (For US Only)
Inventors: ALIMI, Hojabr; (US).
GUTIÉRREZ, Andrés; (US)
Agent: SKLAR, Steven, H.; LEYDIG, VOIT & MAYER, LTD., Two Prudential Plaza, Suite 4900, 180 N. Stetson Ave., Chicago, Illinois 60601-6731 (US)
Priority Data:
60/760,557 20.01.2006 US
60/760,567 20.01.2006 US
60/760,635 20.01.2006 US
60/760,645 20.01.2006 US
Title (EN) METHODS OF TREATING OR PREVENTING SINUSITIS WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION
(FR) PROCÉDÉS POUR TRAITER OU PRÉVENIR LA SINUSITE AU MOYEN D'UNE SOLUTION AQUEUSE À POTENTIEL D'OXYDO-RÉDUCTION
Abstract: front page image
(EN)Provided is a method for preventing or treating sinusitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers. The ORP water solution can be administered alone or, e.g., in combination with one or more additional therapeutic agents.
(FR)La présente invention concerne un procédé pour prévenir ou pour traiter la sinusite par administration d'une quantité active d'un point de vue thérapeutique, d'une solution aqueuse à potentiel d'oxydo-réduction (oxidative reduction potential / ORP) qui est stable pendant au moins environ vingt-quatre heure. La solution aqueuse à ORP administrée conformément à l'invention, peut être combinée à un ou plusieurs excipients appropriés. La solution aqueuse à ORP peut être administrée seule ou, par ex., en combinaison avec un ou plusieurs agents thérapeutiques supplémentaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)